Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy

Journal:

Nature Communications

Published:

2026-02-20

DOI:

10.1038/s41467-026-69857-4

Affiliations:

12

Authors:

28

Go to article

Institutions	Authors	Share
Beckman Research Institute, City of Hope, United States of America (USA)	19.500000 19.500000	0.70
City of Hope, United States of America (USA)	4.000000	0.14
The University of British Columbia (UBC), Canada	1.666667	0.06
The Translational Genomics Research Institute (TGen), United States of America (USA)	1.500000	0.05
BC Children's Hospital and Sunny Hill Health Centre for Children, PHSA, Canada	1.083333	0.04
BC Cancer Agency (BCCA), PHSA, Canada	0.250000	0.01

Interested in Oncology and Carcinogenesis?